425874004: Hydroxyapatite (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2661149011 Hydroxyapatite (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2673674016 Hydroxyapatite en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4608311000005111 hydroxyapatit da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
hydroxyapatit	Is a	Mineral supplement (substance)	false	Inferred relationship	Some
hydroxyapatit	Is a	Calcium phosphate	false	Inferred relationship	Some
hydroxyapatit	Is a	phosphatsalt	false	Inferred relationship	Some
hydroxyapatit	Is a	Calcium compound	false	Inferred relationship	Some
hydroxyapatit	Is a	bestanddel af sten	false	Inferred relationship	Some
hydroxyapatit	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Calcium phosphate	false	Inferred relationship	Some
hydroxyapatit	Is a	Phosphate	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Durapatite (substance)	Is a	False	hydroxyapatit	Inferred relationship	Some
Hydroxyapatite 3.32 g oral granules sachet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	hydroxyapatit	Inferred relationship	Some
Hydroxyapatite 830 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	hydroxyapatit	Inferred relationship	Some
Hydroxyapatite-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	hydroxyapatit	Inferred relationship	Some	1
Hydroxyapatite 830 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	hydroxyapatit	Inferred relationship	Some	1
Hydroxyapatite 830 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	hydroxyapatit	Inferred relationship	Some	1
Durapatite (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	False	hydroxyapatit	Inferred relationship	Some
Hydroxyapatite 830 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	hydroxyapatit	Inferred relationship	Some	1
Hydroxyapatite-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	hydroxyapatit	Inferred relationship	Some	1
Hydroxyapatite 3.32 g oral granules sachet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	hydroxyapatit	Inferred relationship	Some	1
Hydroxyapatite 3.32 g oral granules sachet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	hydroxyapatit	Inferred relationship	Some	1
Hydroxyapatite only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	hydroxyapatit	Inferred relationship	Some	1
Hydroxyapatite only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	hydroxyapatit	Inferred relationship	Some	1
Carmellose- and hydroxyapatite-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	hydroxyapatit	Inferred relationship	Some	2
Hydroxyapatite-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	hydroxyapatit	Inferred relationship	Some	1
Carmellose- and hydroxyapatite-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	hydroxyapatit	Inferred relationship	Some	2
Carmellose and hydroxyapatite only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	hydroxyapatit	Inferred relationship	Some	2
Carmellose and hydroxyapatite only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	hydroxyapatit	Inferred relationship	Some	2

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)